Aromatase inhibitors or gonadotropin‐releasing hormone agonists for the management of uterine adenomyosis: a randomized controlled trial
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Objective. To compare the efficacy of aromatase inhibitor vs. gonadotrophin‐releasing hormone agonists in treating premenopausal women with uterine adenomyosis. Design. A prospective randomized controlled study. Setting. A university hospital and a private practice setting. Population. Thirty‐two patients with uterine adenomyosis. Methods. Patients were randomly allocated to receive oral letrozole (2.5mg/day) or a subcutaneous gonadotropin‐releasing hormone agonist (goserelin, 3.6mg) for 12 weeks. Uterine and adenomyoma volumes were determined at baseline and during treatment at four, eight and 12 weeks. Outcome measures. Measurements were performed at baseline and during treatment at four, eight 8 and 12 weeks, and mean values were calculated. Symptoms at the start and after 12 weeks were evaluated. Results. No significant differences in the total uterine size between the post treatment uterine volumes in the two groups (20.1, 15.4 and 13.0cm 3 vs. 21.7, 15.1 and 11.7cm 3, at four, eight and 12 weeks, respectively). Total adenomyoma volume decreased by 8.6, 29.7 and 40.9% vs. 5.7, 34.6 and 49.1% after four, eight and 12 weeks of treatment, in group A and B, respectively. Two patients became pregnant in group A during treatment. Conclusions. Aromatase inhibitors are as effective as gonadotropin‐releasing hormone agonists in reducing adenomyoma volume and improving symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aromatase expression in endometriosis.
Noble, L. S., Simpson, E. R., Johns, A., & Bulun, S. E. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550748 · Cited by 566 · cited 1×
“There have been recent reports of extraordinary aromatase activity in uterine adenomyosis and endometriosis tissue, which is believed to be related to local estrogen production (10,11).”
BackgroundKitawaki, J., Noguchi, T., Amatsu, T., Maeda, K., Tsukamoto, K., Yamamoto, T., Fushiki, S., Osawa, Y., & Honjo, H. (1997) · Biology of Reproduction · doi:10.1095/biolreprod57.3.514 · Cited by 305
Treatment of severe postmenopausal endometriosis with an aromatase inhibitor
Takayama, K., Zeitoun, K., Gunby, R. T., Sasano, H., Carr, B. R., & Bulun, S. E. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00022-3 · Cited by 270
Parsanezhad, M. E., Azmoon, M., Alborzi, S., Rajaeefard, A., Zarei, A., Kazerooni, T., Frank, V., & Schmidt, E. H. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.09.064 · Cited by 149
Adenomyosis: the pathophysiology of an oestrogen-dependent disease
Kitawaki, J. (2006) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2006.01.010 · Cited by 143
Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review
Ferrero, S., Gillott, D. J., Venturini, P. L., & Remorgida, V. (2011) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-9-89 · Cited by 109
Cited by
Data integrity of 35 randomised controlled trials in women' health
Bordewijk, E. M., Wang, R., Askie, L. M., Gurrin, L. C., Thornton, J. G., van Wely, M., Li, W., & Mol, B. W. (2020) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2020.04.016 · Cited by 66
Endometriosis: a life cycle approach?
Brosens, I., Puttemans, P., & Benagiano, G. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.03.009 · Cited by 66
Conservative management of uterine adenomyosis: medical vs. surgical approach
Stratopoulou, C. A., Donnez, J., & Dolmans, M.-M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10214878 · Cited by 62
“To the best of our knowledge, only one prospective study involving 32 patients has analyzed the effectiveness of letrozole compared to GnRH agonist in treating adenomyosis [67].”
BackgroundAu, L. S., Qu, L., Nielsen, J., Ge, Z., Gurrin, L. C., Mol, B. W., & Wang, R. (2025) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2025.111672 · Cited by 9
Metadata
- Authors
- BADAWY, A. M., ELNASHAR, A. M., & MOSBAH, A. A.
- Venue
- Acta Obstetricia et Gynecologica Scandinavica
- Publisher
- Wiley
- Published
- 2012-03-20
- Volume
- 91
- Issue
- 4
- Pages
- 489-495
- ISSN
- 0001-6349 (ISSN-L)
- 1600-0412
- OpenAlex
- W1925466818
- Cited by
- 99
- References
- 6
- FWCI
- 5.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Aromatase inhibitors or gonadotropin‐releasing hormone agonists for the management of uterine adenomyosis: a randomized controlled trial. https://app.cochat.ai/papers/10.1111/j.1600-0412.2012.01350.x
- The paper
- BADAWY, A. M., ELNASHAR, A. M., & MOSBAH, A. A. (2012). Aromatase inhibitors or gonadotropin‐releasing hormone agonists for the management of uterine adenomyosis: a randomized controlled trial. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/j.1600-0412.2012.01350.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.